Skip to main content

Table 1 Numbers of tumor samples that have clinical information available regarding response-to-chemotherapy, for each cancer type (n.b., the total number of labeled tumor samples exceeds the total number of patients because some patients had multiple tumors)

From: Predicting chemotherapy response using a variational autoencoder approach

Cancer type Total number of samples (labeled and unlabeled) Number of labeled samples Proportion of labeled samples Class balance ratio (responding/progressive)
Breast invasive carcinoma (BRCA) 1217 394 0.324 8.61
Colon adenocarcinomas (COAD) 512 117 0.229 1.72
Bladder carcinoma (BLCA) 430 115 0.267 0.95
Pancreatic adenocarcinoma (PAAD) 182 115 0.632 0.77
Sarcoma (SARC) 265 65 0.245 0.82
Sum 2606 806   
  1. Each cancer type’s TCGA abbreviation is shown in parentheses